SNTI Senti Biosciences Quarterly EPS earnings growth

Official company branding of sentibio.com (SNTI)

Senti Biosciences, Inc. (SNTI) develops programmable medicines activated by tumor signals. The company's capital base relies on grants and partnerships with pharmaceutical behemoths. Currently, the business is narrowing its portfolio to accelerate the commercialization of assets. Quarterly EPS growth on the GURU.Markets chart demonstrates current volatility, where 27.10 reflects the latest metric value, helping investors avoid a value trap when analyzing operating results.

Senti Biosciences (SNTI) Year-over-year earnings per share growth for the last twelve months: for the period 04/28/2023 - 11/14/2026

Senti Biosciences, Inc. (SNTI) - metric breakdowns and financial figures

- share price and expert price forecast:
Stock Price sentibio.com|SNTI - Consensus Target
- market capitalization data:
Market Capitalization Senti Biosciences Inc|SNTI - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Senti Biosciences|SNTI - Company Book Value|Market Value to Book Value Ratio sentibio.com|SNTI - Aggregate Company Assets
- company liabilities and liquidity data:
Total Debt to Equity Ratio Senti Biosciences, Inc.|SNTI - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital sentibio.com|SNTI - Company Total Indebtedness|Debts to Book Capitalization Senti Biosciences Inc|SNTI - Long-Term Debt|Company Short-Term Debt Senti Biosciences|Quick Ratio sentibio.com
- earnings and market multiples details:
SNTI - Company Net Income|Future Profit Senti Biosciences, Inc.|SNTI - Company Value to Net Income|Projected Price to Earnings sentibio.com|SNTI - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Senti Biosciences Inc|SNTI - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Senti Biosciences|SNTI - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months sentibio.com|SNTI - Earnings per share increase in current year|Earnings growth forecast for next year Senti Biosciences, Inc.
- sales volume and revenue information:
SNTI - Revenue and Sales Volume|Company Projected Revenue sentibio.com|SNTI - Price-to-Sales Ratio|Forward Price-to-Revenue Multiple Senti Biosciences Inc
Fundamental company analysis:Senti Bio - SNTI
Finished products of Senti Biosciences, Inc.

For the biotech sector company Senti Biosciences (SNTI), which implements eco-friendly reagent disposal cycles, quarterly EPS progress on the GURU.Markets platform serves as an indicator of operational efficiency. This metric measures net income per share dynamics while filtering out market noise through daily recalculations, allowing investors to assess the business's real financial stability and the risk of correction during abnormally high values.

Analysis of competing companies

LEGN: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Sana Biotechnology Inc|AUTL (Autolus Pharma) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Allogene Corp ALLO|Year-over-year earnings per share growth for the last twelve months Cartesian Therapeutics (RNAC)|Year-over-year earnings per share growth for the last twelve months CLLS (cellectis.com)|Year-over-year earnings per share growth for the last twelve months Caribou Biosciences, Inc. CRBU|Instil Bio Inc. - Year-over-year earnings per share growth for the last twelve months|GNTA: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months IPSC (Century Therapeutics)|JSPR: Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Adaptimmune Therapeutics ADAP|CERO (CERo Therapeutics Holdings, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alaunos TCRT|Year-over-year earnings per share growth for the last twelve months Achilles Therapeutics (ACHL)|CARGO Therapeutics, Inc - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth PSTX (Poseida Therapeutics)|2seventybio.com (TSVT) - Earnings per share growth in annualized terms for the last twelve months|GRCL: Year-over-year net earnings per share growth for the last 12 months